Solitary solutions to an androgen-deprivation prostate cancer treatment model

被引：3

作者：

Telksnys, T. ^{[1
]}

Timofejeva, I. ^{[1
]}

Navickas, Z. ^{[1
]}

Marcinkevicius, R. ^{[2
]}

Mickevicius, R. ^{[3
]}

Ragulskis, M. ^{[1
]}

机构：

[1] Kaunas Univ Technol, Ctr Nonlinear Syst, Studentu 50-147, LT-51368 Kaunas, Lithuania

[2] Kaunas Univ Technol, Dept Software Engn, Studentu 50-415, LT-51368 Kaunas, Lithuania

[3] Lithuanian Univ Hlth Sci, Urol Clin, Eiveniu 2, LT-50009 Kaunas, Lithuania

来源：

MATHEMATICAL METHODS IN THE APPLIED SCIENCES | 2020年 / 43卷 / 07期

关键词：

androgen deprivation therapy; prostate cancer model; solitary solution; IDENTIFICATION; SYSTEMS;

D O I：

10.1002/mma.6168

中图分类号：

O29 [应用数学];

学科分类号：

070104 ;

摘要：

A model of androgen deprivation treatment for prostate cancer is considered in this paper. Bright/dark solitary solutions to the model are constructed using inverse balancing and generalized differential operator techniques. It is shown that solitary solutions correspond to biomedically relevant sets of model parameters. Dynamical properties of solitary solutions are analyzed in the phase plane. It is demonstrated that such solutions closely reflect the real-world phenomena observed during androgen deprivation treatment. Computational experiments are used to illustrate these effects.

引用

页码：3995 / 4006

页数：12

共 50 条

[1] Timing of androgen-deprivation therapy in prostate cancer
Nandagopal, Lakshminarayanan
LANCET ONCOLOGY, 2017, 18 (11): : E634 - E634
[2] Insomnia and androgen-deprivation therapy for prostate cancer
Savard, J.
Ivers, H.
Simard, S.
PSYCHO-ONCOLOGY, 2007, 16 (09) : S150 - S151
[3] Androgen-Deprivation Bone Loss in Patients With Prostate Cancer
Abarado, Cynthia
Mahon, Suzanne M.
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (02) : 191 - 198
[4] Biopsychosocial impact of prostate cancer and androgen-deprivation therapy
Tripp, Dean A.
Verreault, Phylicia
Tong, Steven
Izard, Jason
Black, Angela
Siemens, D. Robert
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (10): : 338 - 343
[5] Complications of androgen-deprivation therapy in men with prostate cancer
Chen A.C.
Petrylak D.P.
Current Urology Reports, 2005, 6 (3) : 210 - 216
[6] Androgen-deprivation therapy in the management of neuroendocrine prostate cancer
Martinez-Cornelio, Andres
Gonzalez-Perez, Juventino
de Jesus Tabares-Garcia, Felipe
Ramos-Salgado, Francisco
Alvarado-Cabrero, Isabel
Hernandez-Toriz, Narciso
CIRUGIA Y CIRUJANOS, 2009, 77 (04): : 273 - 278
[7] Timing of androgen-deprivation therapy in prostate cancer Reply
Duchesne, Gillian M.
Woo, Henry H.
LANCET ONCOLOGY, 2017, 18 (11): : E635 - E635
[8] Depression and androgen-deprivation therapy for advanced prostate cancer
Savard, J.
Simard, S.
Hervouet, S.
Ivers, H.
Rioux, D.
PSYCHO-ONCOLOGY, 2007, 16 (09) : S151 - S152
[9] Depression and androgen-deprivation therapy for advanced prostate cancer
Savard, Josee
Simard, Sebastian
Hervouet, Severine
Ivers, Hans
Rioux, Dominique
ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S89 - S89
[10] Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
Smith, Matthew R.
Saad, Fred
Egerdie, Blair
Sieber, Paul R.
Tammela, Teuvo L. J.
Ke, Chunlei
Leder, Benjamin Z.
Goessl, Carsten
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3271 - 3276

← 1 2 3 4 5 →